S&P Futures
6,018.25 +31.25 (+0.52%) Dow Futures
44,710.00 +315.00 (+0.71%) Nasdaq Futures
20,971.75 +122.00 (+0.59%) Russell 2000 Futures
2,438.40 +24.80 (+1.03%) Crude Oil
71.02 -0.22 (-0.31%) Gold
2,685.60 -26.60 (-0.98%)
Sintx Technologies, Inc. (SINT)
Pre-Market:
| Previous Close | 4.3000 |
| Open | 4.1400 |
| Bid | 4.9800 x 100 |
| Ask | 5.1700 x 100 |
| Day's Range | 4.1400 - 5.5780 |
| 52 Week Range | 2.0100 - 105.8000 |
| Volume | |
| Avg. Volume | 2,054,089 |
| Market Cap | 6.661M |
| Beta (5Y Monthly) | 1.37 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -122.8300 |
| Earnings Date | Jan 21, 2025 - Jan 27, 2025 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 70.00 |
GlobeNewswireSINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment
Salt Lake City, UT, Nov. 21, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and technical applications, announces the signing of a Joint Development Agreement (JDA) with NED Medical Inc., an innovative developer of oncology embolization therapy technologies. This collaboration aims to accelerate the development of advanced ceramic-based m
TipRanksSintx Technologies Initiates Stock Repurchase Program
An update from Sintx Technologies ( (SINT) ) is now available. SINTX Technologies has launched a stock repurchase program to buy back up to $500,000 of its common stock, aiming to boost shareholder value and optimize capital structure. This move reflects SINTX’s confidence in its strategic direction and commitment to leveraging its strong balance sheet. Managed by Maxim Group, the program’s timing and amount of repurchases will depend on market conditions and company needs, potentially increasin
